3Q23 & 9M23 Performance Overview

Private investment stage portfolio companies EXTERNALLY VALUED & 18 CLINICS & DIAGNOSTICS BUSINESS OVERVIEW (CONT'D) Community Clinics Outpatient and basic inpatient services in regional towns and municipalities 17 Polyclinics CLINICS (3Q23) Outpatient diagnostic and treatment services in Tbilisi and major regional cities c.291,300 Market share by number of registered patients* 632,200 GCAP Clinics Geo Hospitals 319,000 22% Medcapital 136,000 Market share by registered patients Registered patient in Tbilisi Medison 91,000 c.632,200 Registered patient in Georgia Other *As of 30-Sep-23. NET REVENUE, CLINICS c.164,000 GEORGIA CAPITAL DIAGNOSTICS (3Q23) Average number of tests per patient 3.4 Number of patients served 22% 11% c.560,000 GEL 7.5 5% Number of tests performed Average revenue per test (excluding COVID-19) 3% 16% 1,659,000 59% Retail portion in total revenue EBITDA, CLINICS (excl. IFRS 16) GEL million Gross profit margin (%) 42.6% 44.8% 46.5% 44.1% 42.4% 41.7% 43.6% 42.4% 43.5% 15.4% 19.9% 20.1% 19.9% 13.5% 8.9% 31.2% 14.8% 19.7% EBITDA margin (%, excl. IFRS 16) EBITDA, DIAGNOSTICS (excl. IFRS 16) EBITDA margin (%, excl. IFRS 16) 3.2% 12.3% 23.8% 3.3% -0.2% 4.2% 5.9% 6.2% +3.8% 70.5 44.2 46.3 33.3 65.8 24.9 +11.5% 37.8 21.0 21.4 51.1 49.2 18.9 15.8 GEL million 14.1 39.8% 7.3 8.9 9.4 5.9 17.9 19.9 23.2 24.9 37.2 40.9 14.1 5.U 16.1 46 10.3 9.0 NMF 7.4 5.2 1.3 GEL million -12.4% NMF 1.8 0.7 1.0 0.8 0.2 30.3 35.3 0.2 0.0 2018 2019 2020 2021 2022 3Q22 3Q23 Polyclinics ■Community Clinics 2019 2020 2021 2022 9M22 9M23 2018 2019 2020 2021 2022 3Q22 3Q23 9M22 9M23 3Q22 3Q23 9M22 9M23 71

View entire presentation